Home › Funds › BOSTON RESEARCH & MANAGEMENT INC › ABBV

BOSTON RESEARCH & MANAGEMENT INC position in ABBV

ABBVIE INC · Health Care

BOSTON RESEARCH & MANAGEMENT INC reported holding 47,018 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$12.3M, representing 2.71% of its reported portfolio and ranking #6 among its reported holdings. BOSTON RESEARCH & MANAGEMENT INC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)47.02K sh
Reported value held$12.30M
Portfolio Weight2.71%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BOSTON RESEARCH & MANAGEMENT INC's ABBV position evolved

BOSTON RESEARCH & MANAGEMENT INC first disclosed a stake in ABBV in Q3 2023 at 53,157 shares (US$7.9M). The position peaked in Q3 2026 at 47,018 shares, worth US$12.3M. Across 13 filings, BOSTON RESEARCH & MANAGEMENT INC increased the stake 1 time(s), trimmed it 6 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 47,018 shares valued at US$12.3M — a reduction of -1,111 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 53.16K $7.92M New
Q4 2023 53.75K $8.33M Add
Q1 2024 53.04K $9.66M Reduce
Q2 2024 52.41K $8.99M Reduce
Q3 2024 52.50K $10.37M Hold
Q4 2024 52.40K $9.31M Hold
Q1 2025 51.12K $10.71M Reduce
Q2 2025 51.29K $9.52M Hold
Q3 2025 51.14K $11.84M Hold
Q4 2025 48.69K $11.12M Reduce
Q1 2026 48.35K $10.52M Reduce
Q2 2026 48.13K $12.11M Hold
Q3 2026 47.02K $12.30M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has BOSTON RESEARCH & MANAGEMENT INC held ABBV?

BOSTON RESEARCH & MANAGEMENT INC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BOSTON RESEARCH & MANAGEMENT INC's current position in ABBV?

As of Q3 2026, BOSTON RESEARCH & MANAGEMENT INC holds 47.02K shares of ABBV (ABBVIE INC), valued at $12.30M, representing 2.71% of its reported portfolio and ranking #6.

Has BOSTON RESEARCH & MANAGEMENT INC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), BOSTON RESEARCH & MANAGEMENT INC reduced its position in ABBV. The position peaked in Q3 2026 at 47.02K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.